Ethical issues in colorectal cancer screening

Best Practice and Research: Clinical Gastroenterology

Volumn 28, Issue 2, 2014, Pages 315-326

  Van Dam, Leonie ^a   Bretthauer, Michael ^b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colorectal cancer; CT colonography; Endoscopy; Ethics; Faecal occult blood test; screening

Indexed keywords

ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INTESTINE PREPARATION; LABORATORY DIAGNOSIS; MASS SCREENING; MEDICAL ETHICS; MEDICALIZATION; MORTALITY; OCCULT BLOOD; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING TEST; SIGMOIDOSCOPY; SYSTEMATIC REVIEW (TOPIC);

COLORECTAL CANCER; CT-COLONOGRAPHY; ENDOSCOPY; ETHICS; FAECAL OCCULT BLOOD TEST; SCREENING;

COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; ENDOSCOPY, GASTROINTESTINAL; HUMANS; MASS SCREENING; OCCULT BLOOD;

EID: 84899793532     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2014.03.002     Document Type: Review

References (94)

1. V.A. Moyer Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 156 12 2012 880 891 W312
2. P. Autier, M. Boniol, R. Middleton, J.F. Dore, C. Hery, and T. Zheng et al. Advanced breast cancer incidence following population-based mammographic screening Ann Oncol 22 8 2011 1726 1735
3. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 9040 1996 1467 1471
4. J.S. Mandel, J.H. Bond, T.R. Church, D.C. Snover, G.M. Bradley, and L.M. Schuman et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Studyh N Engl J Med 328 19 1993 1365 1371
5. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, and T.W. Balfour et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 9040 1996 1472 1477
6. H.E. Karim-Kos, V.E. de, I. Soerjomataram, V. Lemmens, S. Siesling, and J.W. Coebergh Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s Eur J Cancer 44 10 2008 1345 1389
7. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 4 2009 225 249
8. D.A. Etzioni, R.W. Beart Jr., R.D. Madoff, and G.T. Ault Impact of the aging population on the demand for colorectal procedures Dis Colon Rectum 52 4 2009 583 590 discussion 90-1
9. S.J. Winawer Natural history of colorectal cancer Am J Med 106 1A 1999 3S 6S discussion 50S-1S
10. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 19 2004 1420 1425
11. P.L. McClements, V. Madurasinghe, C.S. Thomson, C.G. Fraser, F.A. Carey, and R.J. Steele et al. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends Cancer Epidemiol 36 4 2012 e232 e242
12. P. Ellul, E. Fogden, C.L. Simpson, C.L. Nickerson, B.C. McKaig, and E.T. Swarbrick et al. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre Colorectal Dis 12 5 2010 420 422
13. Commission of the European Communities B Council recommendation on cancer screening 2003
14. J.J. Sung, J.Y. Lau, G.P. Young, Y. Sano, H.M. Chiu, and J.S. Byeon et al. Asia Pacific consensus recommendations for colorectal cancer screening Gut 57 8 2008 1166 1176
15. R.A. Smith, V. Cokkinides, D. Brooks, D. Saslow, and O.W. Brawley Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin 60 2 2010 99 119
16. D. Lieberman Colon cancer screening and surveillance controversies Curr Opin Gastroenterol 25 5 2009 422 427
17. A.H. van Roon, S.L. Goede, M. van Ballegooijen, A.J. van Vuuren, C.W. Looman, and K. Biermann et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening Gut 62 3 2013 409 415
18. European Commission N.P.J. Segnan, L. von Karsa, European guidelines for quality assurance in colorectal cancer screening and diagnosis 14 November 2011 Publications Office of the European Union Luxembourg
19. P. Hewitson, P. Glasziou, E. Watson, B. Towler, and L. Irwig Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update Am J Gastroenterol 103 6 2008 1541 1549
20. O. Holme, M. Bretthauer, A. Fretheim, J. Odgaard-Jensen, and G. Hoff Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals Cochrane Database Syst Rev 9 2013 CD009259
21. L. Hol, M.E. van Leerdam, M. van Ballegooijen, A.J. van Vuuren, D.H. van, and J.C. Reijerink et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Gut 59 1 2010 62 68
22. N. Segnan, P. Armaroli, L. Bonelli, M. Risio, S. Sciallero, and M. Zappa et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE J Natl Cancer Inst 103 17 2011 1310 1322
23. N. Segnan, C. Senore, B. Andreoni, A. Arrigoni, L. Bisanti, and A. Cardelli et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates J Natl Cancer Inst 97 5 2005 347 357
24. J.L. Weissfeld, R.E. Schoen, P.F. Pinsky, R.S. Bresalier, T. Church, and S. Yurgalevitch et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial J Natl Cancer Inst 97 13 2005 989 997
25. G. Gondal, T. Grotmol, B. Hofstad, M. Bretthauer, T.J. Eide, and G. Hoff The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years Scand J Gastroenterol 38 6 2003 635 642
26. W.S. Atkin, R. Edwards, I. Kralj-Hans, K. Wooldrage, A.R. Hart, and J.M. Northover et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 9726 2010 1624 1633
27. G. Hoff, T. Grotmol, E. Skovlund, and M. Bretthauer Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial BMJ 338 2009 b1846
28. R.E. Schoen, P.F. Pinsky, J.L. Weissfeld, L.A. Yokochi, T. Church, and A.O. Laiyemo et al. Colorectal-Cancer incidence and mortality with screening flexible sigmoidoscopy N Engl J Med 366 2012 2345 2357
29. E. Thiis-Evensen, G.S. Hoff, J. Sauar, B.M. Majak, and M.H. Vatn Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years Gut 45 6 1999 834 839
30. H. Singh, Z. Nugent, A.A. Demers, E.V. Kliewer, S.M. Mahmud, and C.N. Bernstein The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer Gastroenterology 139 4 2010 1128 1137
31. B. Levin, D.A. Lieberman, B. McFarland, K.S. Andrews, D. Brooks, and J. Bond et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 5 2008 1570 1595
32. H. Brenner, J. Chang-Claude, C.M. Seiler, T. Sturmer, and M. Hoffmeister Does a negative screening colonoscopy ever need to be repeated? Gut 55 8 2006 1145 1150
33. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice Med J Aust 184 11 2006 546 550
34. N. Segnan, C. Senore, B. Andreoni, A. Azzoni, L. Bisanti, and A. Cardelli et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening Gastroenterology 132 7 2007 2304 2312
35. M. Corbett, S.L. Chambers, B. Shadbolt, L.C. Hillman, and D. Taupin Colonoscopy screening for colorectal cancer: the outcomes of two recruitment methods Med J Aust 181 8 2004 423 427
36. E.M. Stoop, M.C. de Haan, T.R. de Wijkerslooth, P.M. Bossuyt, M. van Ballegooijen, and C.Y. Nio et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial Lancet Oncol 13 1 2012 55 64
37. D. Lisi, C. Hassan, and M. Crespi Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study Dig Liver Dis 42 5 2010 371 376
38. C.P. Pox, L. Altenhofen, H. Brenner, A. Theilmeier, D. Von Stillfried, and W. Schmiegel Efficacy of a nationwide screening colonoscopy program for colorectal cancer Gastroenterology 142 7 2012 1460 1467 e2
39. S.J. Winawer, A.G. Zauber, M.N. Ho, M.J. O'Brien, L.S. Gottlieb, and S.S. Sternberg et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 27 1993 1977 1981
40. A.G. Zauber, I. Lansdorp-Vogelaar, A.B. Knudsen, J. Wilschut, B.M. van, and K.M. Kuntz Evaluating test strategies for colorectal Cancer screening: a decision analysis for the U.S. Preventive Services Task Force Ann Intern Med 149 2008 659 669
41. V. Panteris, J. Haringsma, and E.J. Kuipers Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy Endoscopy 41 11 2009 941 951
42. J.T. Edwards, R.M. Mendelson, L. Fritschi, N.M. Foster, C. Wood, and D. Murray et al. Colorectal neoplasia screening with CT colonography in average-risk asymptomatic subjects: community-based study Radiology 230 2 2004 459 464
43. R.G. Scott, J.T. Edwards, L. Fritschi, N.M. Foster, R.M. Mendelson, and G.M. Forbes Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects Am J Gastroenterol 99 6 2004 1145 1151
44. C. Hassan, and P.J. Pickhardt Cost-effectiveness of CT colonography Radiol Clin North Am 51 1 2013 89 97
45. P.J. Pickhardt Incidence of colonic perforation at CT colonography: review of existing data and implications for screening of asymptomatic adults Radiology 239 2 2006 313 316
46. J. Sosna, A. Blachar, M. Amitai, E. Barmeir, N. Peled, and S.N. Goldberg et al. Colonic perforation at CT colonography: assessment of risk in a multicenter large cohort Radiology 239 2 2006 457 463
47. C.P. Pox, and W. Schmiegel Role of CT colonography in colorectal cancer screening: risks and benefits Gut 59 5 2010 692 700
48. M.C. de Haan, S. Halligan, and J. Stoker Does CT colonography have a role for population-based colorectal cancer screening? Eur Radiol 22 7 2012 1495 1503
49. J.M. Wilson, and Y.G. Jungner Principles and practice of mass screening for disease Public Health Pap 65 4 1968 281 393
50. A. Andermann, I. Blancquaert, S. Beauchamp, and V. Dery Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years Bull World Health Organ 86 4 2008 317 319
51. J.S. Goodwin Geriatrics and the limits of modern medicine N Engl J Med 340 16 1999 1283 1285
52. M.F. Verweij Medicalization as a moral problem for preventive medicine Bioethics 13 2 1999 89 113
53. K.J. Jorgensen, and P.C. Gotzsche Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends BMJ 339 2009 b2587
54. M. Bretthauer, and M. Kalager Principles, effectiveness and caveats in screening for cancer Br J Surg 100 1 2013 55 65
55. A. Miles, V. Rodrigues, and N. Sevdalis The effect of information about false negative and false positive rates on people's attitudes towards colorectal cancer screening using faecal occult blood testing (FOBt) Patient Educ Couns 93 2 2013 342 349
56. L. Irwig, K. McCaffery, G. Salkeld, and P. Bossuyt Informed choice for screening: implications for evaluation BMJ 332 7550 2006 1148 1150
57. I.J. Korfage, M. van Ballegooijen, B. Wauben, J.D. Habbema, and M.L. Essink-Bot Informed choice on Pap smear still limited by lack of knowledge on the meaning of false-positive or false-negative test results Patient Educ Couns 85 2 2011 214 218
58. A.F. van Rijn, L.G. van Rossum, M. Deutekom, R.J. Laheij, P.M. Bossuyt, and P. Fockens et al. Getting adequate information across to colorectal cancer screening subjects can be difficult J Med Screen 15 3 2008 149 152
59. S.K. Smith, L. Trevena, J.M. Simpson, A. Barratt, D. Nutbeam, and K.J. McCaffery A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial BMJ 341 2010 c5370
60. L.J. Trevena, L. Irwig, and A. Barratt Randomized trial of a self-administered decision aid for colorectal cancer screening J Med Screen 15 2 2008 76 82
61. A.M. O'Connor, C.L. Bennett, D. Stacey, M. Barry, N.F. Col, and K.B. Eden et al. Decision aids for people facing health treatment or screening decisions Cochrane Database Syst Rev 3 2009 CD001431
62. L. van Dam, E.J. Kuipers, E.W. Steyerberg, M.E. van Leerdam, and I.D. de Beaufort The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies? Lancet Oncol 14 1 2013 e38 e46
63. J. Eaden, M.K. Mayberry, A. Sherr, and J.F. Mayberry Screening: the legal view Public Health 115 3 2001 218 221
64. T.J. Gates Screening for cancer: evaluating the evidence Am Fam Phys 63 3 2001 513 522
65. C. Senore, P. Armaroli, M. Silvani, B. Andreoni, L. Bisanti, and L. Marai et al. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation Am J Gastroenterol 105 1 2010 188 198
66. J. Blom, L. Yin, A. Liden, A. Dolk, B. Jeppsson, and L. Pahlman et al. A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening: importance of self-selection Cancer Epidemiol Biomarkers Prev 17 5 2008 1163 1168
67. S.W. Vernon Participation in colorectal cancer screening: a review J Natl Cancer Inst 89 19 1997 1406 1422
68. N. Bae, S. Park, and S. Lim Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea Eur J Oncol Nurs 18 1 2014 72 77
69. R.A. Hubbard, E. Johnson, R. Hsia, and C.M. Rutter The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening Cancer Epidemiol Biomarkers Prev 22 9 2013 1612 1619
70. L. van Dam, E.J. Kuipers, and M.E. van Leerdam Performance improvements of stool-based screening tests Best Pract Res Clin Gastroenterol 24 4 2010 479 492
71. H. Brenner, U. Haug, and S. Hundt Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests Int J Cancer 127 7 2010 1643 1649
72. H. Brenner, and S. Tao Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy Eur J Cancer 49 14 2013 3049 3054
73. C.K. Wong, R.N. Fedorak, C.I. Prosser, M.E. Stewart, S.V. van Zanten, and D.C. Sadowski The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer Int J Colorectal Dis 27 12 2012 1657 1664
74. D.I. Park, S. Ryu, Y.H. Kim, S.H. Lee, C.K. Lee, and C.S. Eun et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening Am J Gastroenterol 105 9 2010 2017 2025
75. D. Lieberman Progress and challenges in colorectal cancer screening and surveillance Gastroenterology 138 6 2010 2115 2126
76. R.E. Schoen, P.F. Pinsky, J.L. Weissfeld, L.A. Yokochi, T. Church, and A.O. Laiyemo et al. Colorectal cancers not detected by screening flexible sigmoidoscopy in the prostate, lung, colorectal, and ovarian cancer screening trial Gastrointest Endosc 75 3 2012 612 620
77. P.J. Pickhardt, C. Hassan, S. Halligan, and R. Marmo Colorectal cancer: CT colonography and colonoscopy for detection-systematic review and meta-analysis Radiology 259 2 2011 393 405
78. A. Gillberg, E. Ericsson, F. Granstrom, and L.I. Olsson A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer Colorectal Dis 14 9 2012 e539 e546
79. K.L. Taylor, R. Shelby, E. Gelmann, and C. McGuire Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial J Natl Cancer Inst 96 14 2004 1083 1094
80. A. Kapidzic, I.J. Korfage, L. van Dam, A.H. van Roon, J.C. Reijerink, and A.G. Zauber et al. Quality of life in participants of a CRC screening program Br J cancer 107 8 2012 1295 1301
81. K. Brasso, S. Ladelund, B.L. Frederiksen, and T. Jorgensen Psychological distress following fecal occult blood test in colorectal cancer screening-a population-based study Scand J Gastroenterol 45 10 2010 1211 1216
82. M.A. Parker, M.H. Robinson, J.H. Scholefield, and J.D. Hardcastle Psychiatric morbidity and screening for colorectal cancer J Med Screen 9 1 2002 7 10
83. L.M. Schwartz, S. Woloshin, F.J. Fowler Jr., and H.G. Welch Enthusiasm for cancer screening in the United States JAMA 291 1 2004 71 78
84. A. Shaukat, S.J. Mongin, M.S. Geisser, F.A. Lederle, J.H. Bond, and J.S. Mandel et al. Long-term mortality after screening for colorectal cancer N Engl J Med 369 12 2013 1106 1114
85. P. Moayyedi Colorectal cancer screening lacks evidence of benefit Cleve Clin J Med 74 8 2007 545 549-50 52 passim
86. R.J. Steele, and D.H. Brewster Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? No BMJ 343 2011 d6397
87. J. Penston Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes BMJ 343 2011 d6395
88. I. Lansdorp-Vogelaar, B.M. van, A.G. Zauber, J.D. Habbema, and E.J. Kuipers Effect of rising chemotherapy costs on the cost savings of colorectal Cancer screening J Natl Cancer Inst 101 20 2009 1412 1422
89. V.S. Benson, J. Patnick, A.K. Davies, M.R. Nadel, R.A. Smith, and W.S. Atkin Colorectal cancer screening: a comparison of 35 initiatives in 17 countries Int J Cancer 122 6 2008 1357 1367
90. D.K. Rex, D.A. Johnson, J.C. Anderson, P.S. Schoenfeld, C.A. Burke, and J.M. Inadomi American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] Am J Gastroenterol 104 3 2009 739 750
91. K.R. Yabroff, C.N. Klabunde, G. Yuan, T.S. McNeel, M.L. Brown, and D. Casciotti et al. Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med 26 2 2011 177 184
92. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 149 9 2008 627 637
93. D. Gyrd-Hansen, and J. Sogaard Analysing public preferences for cancer screening programmes Health Econ 10 7 2001 617 634
94. M. Nayaradou, C. Berchi, O. Dejardin, and G. Launoy Eliciting population preferences for mass colorectal cancer screening organization Med Decis Making 30 2009 224 233